SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis

Loss of SPRY2 and activation of receptor tyrosine kinases are common events in prostate cancer (PC). However, the molecular basis of their interaction and clinical impact remains to be fully examined. SPRY2 loss may functionally synergize with aberrant cellular signalling to drive PC and to promote...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gao, Meiling, Patel, Rachana, Ahmad, Imran, Fleming, Janis, Edwards, Joanne, McCracken, Stuart, Sahadevan, Kanagasabai, Seywright, Morag, Norman, Jim, Sansom, Owen, Leung, Hing Y
Natura: Artigo
Lingua:Inglês
Pubblicazione: WILEY-VCH Verlag 2012
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494076/
https://ncbi.nlm.nih.gov/pubmed/22649008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.201100944
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi